Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$4.95 USD
-0.25 (-4.81%)
Updated May 20, 2024 04:00 PM ET
After-Market: $4.98 +0.03 (0.61%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Brokerage Reports
Monte Rosa Therapeutics, Inc. [GLUE]
Reports for Purchase
Showing records 1 - 5 ( 5 total )
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; Stay Glued for MRT-2359 Updates Ahead
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM and $11 PT: The QuEEN of Monte Rosa
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Learnings From FASEBs Ubiquitin Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
|